These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26807668)

  • 1. Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment of Helicobacter pylori Infection: Two Pilot Studies.
    Ciccaglione AF; Tavani R; Grossi L; Cellini L; Manzoli L; Marzio L
    Helicobacter; 2016 Oct; 21(5):375-81. PubMed ID: 26807668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study.
    Ciccaglione AF; Cellini L; Grossi L; Manzoli L; Marzio L
    Helicobacter; 2015 Oct; 20(5):390-6. PubMed ID: 25801708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori.
    Ciccaglione AF; Cellini L; Grossi L; Marzio L
    World J Gastroenterol; 2012 Aug; 18(32):4386-90. PubMed ID: 22969203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of rifabutin-based triple therapy in Helicobacter pylori infected patients after two standard treatments.
    González Carro P; Pérez Roldán F; De Pedro Esteban A; Legaz Huidobro ML; Soto Fernández S; Roncero Garcia Escribano O; Esteban López-Jamar JM; Pedraza Martin C; Ruíz Carrillo F
    J Gastroenterol Hepatol; 2007 Jan; 22(1):60-3. PubMed ID: 17201882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures.
    Hsu PI; Wu DC; Chen A; Peng NJ; Tseng HH; Tsay FW; Lo GH; Lu CY; Yu FJ; Lai KH
    Eur J Clin Invest; 2008 Jun; 38(6):404-9. PubMed ID: 18435764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Status of Five Different Regimens for Empiric First-Line Helicobacter pylori Eradication in Turkey.
    Gungor G; Baglıcakoglu M; Kayacetin E; Biyik M; Ucar R; Goktepe H; Ataseven H; Demir A
    Digestion; 2015; 92(2):55-9. PubMed ID: 26183105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies.
    Perri F; Festa V; Clemente R; Villani MR; Quitadamo M; Caruso N; Bergoli ML; Andriulli A
    Am J Gastroenterol; 2001 Jan; 96(1):58-62. PubMed ID: 11197288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifabutin-Containing Triple Therapy Versus Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter, Randomized Controlled Trial.
    Chen J; Guo Y; Huang Y; Ding Z; Wang J; Liang X; Xu P; Han Y; Lu H
    J Infect Dis; 2023 Aug; 228(5):511-518. PubMed ID: 37079894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modified bismuth-containing quadruple therapy including a short course of furazolidone for Helicobacter pylori eradication after sequential therapy failure.
    Fakheri H; Bari Z; Sardarian H
    Helicobacter; 2012 Aug; 17(4):264-8. PubMed ID: 22759325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bismuth-based first-line therapy for Helicobacter pylori eradication in type 2 diabetes mellitus patients.
    Demir M; Göktürk S; Oztürk NA; Serin E; Yilmaz U
    Digestion; 2010; 82(1):47-53. PubMed ID: 20410684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of bismuth addition to sequential treatment on Helicobacter pylori eradication: A pilot study.
    Basyigit S; Kefeli A; Sapmaz F; Yeniova AO; Asilturk Z; Hokkaomeroglu M; Uzman M; Nazligul Y
    Bosn J Basic Med Sci; 2015 Oct; 15(4):50-4. PubMed ID: 26614852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.
    Almeida N; Romãozinho JM; Donato MM; Luxo C; Cardoso O; Cipriano MA; Marinho C; Sofia C
    Helicobacter; 2014 Apr; 19(2):90-7. PubMed ID: 24506175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
    Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
    J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection.
    Borody TJ; Pang G; Wettstein AR; Clancy R; Herdman K; Surace R; Llorente R; Ng C
    Aliment Pharmacol Ther; 2006 Feb; 23(4):481-8. PubMed ID: 16441468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection.
    Saracino IM; Pavoni M; Zullo A; Fiorini G; Saccomanno L; Lazzarotto T; Antonelli G; Cavallo R; Borghi C; Vaira D
    Eur J Intern Med; 2020 Nov; 81():50-53. PubMed ID: 32646659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bismuth-based therapies for the first step eradication of Helicobacter pylori.
    Sezgin O; Altintaş E; Uçbilek E; Tataroğlu C
    Turk J Gastroenterol; 2006 Jun; 17(2):90-3. PubMed ID: 16830288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
    Gisbert JP; Molina-Infante J; Marin AC; Vinagre G; Barrio J; McNicholl AG
    Scand J Gastroenterol; 2013 Jun; 48(6):652-6. PubMed ID: 23556551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial.
    Fakheri H; Taghvaei T; Hosseini V; Bari Z
    Helicobacter; 2012 Feb; 17(1):43-8. PubMed ID: 22221615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of rifabutin- and levofloxacin-based third-line rescue therapies for Helicobacter pylori].
    Jeong MH; Chung JW; Lee SJ; Ha M; Jeong SH; Na S; Na BS; Park SK; Kim YJ; Kwon KA; Ko KI; Jo Y; Hahm KB; Jung HY
    Korean J Gastroenterol; 2012 Jun; 59(6):401-6. PubMed ID: 22735872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.